Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: BREAST - PATHOLOGY , . Treffer: 51

2018

Partl, R; Regitnig, P; Tauber, G; Pötscher, M; Bjelic-Radisic, V; Kapp, KS Radiation-induced morphea-a rare but severe late effect of adjuvant breast irradiation : Case report and review of the literature.
Strahlenther Onkol. 2018; 194(11): 1060-1065. Doi: 10.1007/s00066-018-1336-9 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Alduk, AM; Brcic, I; Podolski, P; Prutki, M Correlation of MRI features and pathohistological prognostic factors in invasive ductal breast carcinoma.
Acta Clin Belg. 2017; 72(5):306-312 Doi: 10.1080/17843286.2016.1266432
Web of Science PubMed FullText FullText_MUG

 

Schramm, A; Schochter, F; Friedl, TWP; de Gregorio, N; Andergassen, U; Alunni-Fabbroni, M; Trapp, E; Jaeger, B; Heinrich, G; Camara, O; Decker, T; Ober, A; Mahner, S; Fehm, TN; Pantel, K; Fasching, PA; Schneeweiss, A; Janni, W; Rack, BK; SUCCESS Study Group Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
Clin Breast Cancer. 2017; 17(4):279-285 Doi: 10.1016/j.clbc.2016.11.008
Web of Science PubMed FullText FullText_MUG

 

Trapp, EK; Majunke, L; Zill, B; Sommer, H; Andergassen, U; Koch, J; Harbeck, N; Mahner, S; Friedl, TWP; Janni, W; Rack, B; Alunni-Fabbroni, M LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells.
Mol Oncol. 2017; 11(11):1508-1526 Doi: 10.1002/1878-0261.12111 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Kammerer, S; Jahn, SW; Winter, E; Eidenhammer, S; Rezania, S; Regitnig, P; Pichler, M; Schreibmayer, W; Bauernhofer, T Critical evaluation of KCNJ3 gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistry.
J Clin Pathol. 2016; 69(12):1116-1121 Doi: 10.1136/jclinpath-2016-203798 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rack, B; Jückstock, J; Trapp, E; Weissenbacher, T; Alunni-Fabbroni, M; Schramm, A; Widschwendter, P; Lato, K; Zwingers, T; Lorenz, R; Tesch, H; Schneeweiss, A; Fasching, P; Mahner, S; Beckmann, MW; Lichtenegger, W; Janni, W; SUCCESS Study Group CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.
Tumour Biol. 2016; 37(10):13769-13775 Doi: 10.1007/s13277-016-5171-2
Web of Science PubMed FullText FullText_MUG

 

Tramm, T; Kim, JY; Leibl, S; Moinfar, F; Tavassoli, FA Expression of C-KIT, CD24, CD44s, and COX2 in benign and non-invasive apocrine lesions of the breast.
Virchows Arch. 2016; 469(3):285-295 Doi: 10.1007/s00428-016-1966-1
Web of Science PubMed FullText FullText_MUG

 

2015

Fastner, G; Reitsamer, R; Ziegler, I; Zehentmayr, F; Fussl, C; Kopp, P; Peintinger, F; Greil, R; Fischer, T; Deutschmann, H; Sedlmayer, F IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.
Int J Cancer. 2015; 136(5): 1193-1201. Doi: 10.1002/ijc.29064 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mann, RM; Balleyguier, C; Baltzer, PA; Bick, U; Colin, C; Cornford, E; Evans, A; Fallenberg, E; Forrai, G; Fuchsjäger, MH; Gilbert, FJ; Helbich, TH; Heywang-Köbrunner, SH; Camps-Herrero, J; Kuhl, CK; Martincich, L; Pediconi, F; Panizza, P; Pina, LJ; Pijnappel, RM; Pinker-Domenig, K; Skaane, P; Sardanelli, F; European Society of Breast Imaging (EUSOBI), with language review by Europa Donna–The European Breast Cancer Coalition Breast MRI: EUSOBI recommendations for women's information.
Eur Radiol. 2015; 25(12):3669-3678 Doi: 10.1007/s00330-015-3807-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Peintinger, F; Sinn, B; Hatzis, C; Albarracin, C; Downs-Kelly, E; Morkowski, J; Gould, R; Symmans, WF Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy.
MODERN PATHOL. 2015; 28(7): 913-920. Doi: 10.1038/modpathol.2015.53 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Kalmar, PI; Oswald, S; Fuchsjäger, MH 54-year old patient with unilateral chronic active mastitis in hyperprolactinemia].
Rofo. 2014; 186(12):1149-1151 Doi: 10.1055/s-0034-1366355 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Puzovic, V; Brcic, I; Ranogajec, I; Jakic-Razumovic, J Prognostic values of ETS-1, MMP-2 and MMP-9 expression and co-expression in breast cancer patients.
Neoplasma. 2014; 61(4): 439-446. Doi: 10.4149/neo_2014_054 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Trivanović, D; Nikolić, S; Krstić, J; Jauković, A; Mojsilović, S; Ilić, V; Okić-Djordjević, I; Santibanez, JF; Jovčić, G; Bugarski, D Characteristics of human adipose mesenchymal stem cells isolated from healthy and cancer affected people and their interactions with human breast cancer cell line MCF-7 in vitro.
Cell Biol Int. 2014; 38(2): 254-265. Doi: 10.1002/cbin.10198
Web of Science PubMed FullText FullText_MUG

 

2013

Aigner, B; Plötz, SG; Schaller, G Triple-negative breast cancer possibly transforming into malignant melanoma due to targeted therapy? A case report and review of literature.
Wien Med Wochenschr. 2013; 163(21-22): 495-498. Doi: 10.1007/s10354-013-0242-0 (- Case Report)
PubMed FullText FullText_MUG

 

Stöger, H Are the new breast cancer subtypes (luminal A, B etc.) of practical impact? Yes].
Dtsch Med Wochenschr. 2013; 138(41):2096-2096 Doi: 10.1055/s-0033-1349531
Web of Science PubMed FullText FullText_MUG

 

2012

Meretoja, TJ; Leidenius, MH; Heikkilä, PS; Boross, G; Sejben, I; Regitnig, P; Luschin-Ebengreuth, G; Žgajnar, J; Perhavec, A; Gazic, B; Lázár, G; Takács, T; Vörös, A; Saidan, ZA; Nadeem, RM; Castellano, I; Sapino, A; Bianchi, S; Vezzosi, V; Barranger, E; Lousquy, R; Arisio, R; Foschini, MP; Imoto, S; Kamma, H; Tvedskov, TF; Kroman, N; Jensen, MB; Audisio, RA; Cserni, G International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer.
J Natl Cancer Inst. 2012; 104(24):1888-1896 Doi: 10.1093/jnci/djs455 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Petricevic, B; Vrbanec, D; Jakic-Razumovic, J; Brcic, I; Rabic, D; Badovinac, T; Ozimec, E; Bali, V Expression of Toll-like receptor 4 and beta 1 integrin in breast cancer.
Med Oncol. 2012; 29(2): 486-494. Doi: 10.1007/s12032-011-9885-0
Web of Science PubMed FullText FullText_MUG

 

2009

Flöry, D; Fuchsjaeger, MW; Weisman, CF; Helbich, TH Advances in breast imaging: a dilemma or progress?
Recent Results Cancer Res. 2009; 173:159-181 Doi: 10.1007/978-3-540-31611-4_10
PubMed FullText FullText_MUG

 

2008

Peintinger, F; Kuerer, HM; McGuire, SE; Bassett, R; Pusztai, L; Symmans, WF Residual specimen cellularity after neoadjuvant chemotherapy for breast cancer.
Br J Surg. 2008; 95(4): 433-437. Doi: 10.1002/bjs.6044
Web of Science PubMed FullText FullText_MUG

 

Reitsamer, R; Menzel, C; Glueck, S; Hitzl, W; Peintinger, F Predictors of mastectomy in a certified breast center - the surgeon is an independent risk factor.
Breast J. 2008; 14(4): 324-329. Doi: 10.1111/j.1524-4741.2008.00592.x
Web of Science PubMed FullText FullText_MUG

 

2007

Kovacs, L; Eder, M; Hollweck, R; Zimmermann, A; Settles, M; Schneider, A; Endlich, M; Mueller, A; Schwenzer-Zimmerer, K; Papadopulos, NA; Biemer, E Comparison between breast volume measurement using 3D surface imaging and classical techniques.
Breast. 2007; 16(2): 137-145. Doi: 10.1016/j.breast.2006.08.001
Web of Science PubMed FullText FullText_MUG

 

Riedl, CC; Ponhold, L; Flory, D; Weber, M; Kroiss, R; Wagner, T; Fuchsjager, M; Helbich, TH Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer
CLIN CANCER RES. 2007; 13(20): 6144-6152. Doi: 10.1158/1078-0432.CCR-07-1270 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2005

Fuchsjaeger, MH; Flory, D; Reiner, CS; Rudas, M; Riedl, CC; Helbich, TH The negative predictive value of electrical impedance scanning in BI-RADS category IV breast lesions
INVEST RADIOL. 2005; 40(7): 478-485. Doi: 10.1097/01.rli.0000167425.34577.d1
Web of Science PubMed FullText FullText_MUG

 

Reitsamer, R; Peintinger, F; Prokop, E; Hitzl, W Pathological complete response rates comparing 3 versus 6 cycles of epidoxorubicin and docetaxel in the neoadjuvant setting of patients with stage II and III breast cancer.
Anticancer Drugs. 2005; 16(8): 867-870. Doi: 10.1097/01.cad.0000173475.59616.b4
Web of Science PubMed FullText FullText_MUG

 

2004

Graf, O; Helbich, TH; Fuchsjager, MH; Hopf, G; Morgun, M; Graf, C; Mallek, R Ultrasound follow-up of palpable solid, probably benign breast lesions (BI-RADS (TM) category III)
ROFO-FORTSCHR RONTG. 2004; 176(9): 1251-1256. Doi: 10.1055/s-2004-813369
Web of Science PubMed FullText FullText_MUG

 

Helbich, TH; Matzek, W; Fuchsjäger, MH Stereotactic and ultrasound-guided breast biopsy.
Eur Radiol. 2004; 14(3): 383-393. Doi: 10.1007/s00330-003-2141-z
PubMed FullText FullText_MUG

 

2003

Malich, A; Fuchsjager, M Electrical impedance scanning in classifying suspicious breast lesions
Invest Radiol. 2003; 38(5):302-303 Doi: 10.1097/01.RLI.0000064340.32601.3d
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Reitsamer, R; Menzel, C; Peintinger, F; Cimpoca, W; Glück, S; Sinzinger, G; Rettenbacher, L; Kässmann, H; Hoffmann, A; Prokop, E; Strasser, F; Kiesler, J; Hutarew, G; Dietze, O Sentinel lymph node biopsy in breast cancer patients--results and experience after 500 sentinel lymph node biopsies].
Gynakol Geburtshilfliche Rundsch. 2003; 43(2):98-103 Doi: 10.1159/000069162
PubMed FullText FullText_MUG

 

Reitsamer, R; Peintinger, F; Rettenbacher, L; Prokop, E Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
J Surg Oncol. 2003; 84(2):63-67 Doi: 10.1002/jso.10294
Web of Science PubMed FullText FullText_MUG

 

2002

Bratthauer, GL; Moinfar, F; Stamatakos, MD; Mezzetti, TP; Shekitka, KM; Man, YG; Tavassoli, FA Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias.
Hum Pathol. 2002; 33(6):620-627 Doi: 10.1053%2Fhupa.2002.124789
Web of Science PubMed FullText FullText_MUG

 

Fuchsjäger, MH; Helbich, TH In situ ductal carcinoma of the breast: a diagnostic challenge.
Wien Med Wochenschr Suppl. 2002; 14(113):69-73
PubMed

 

Fuchsjager, MH; Helbich, TH; Ringl, H; Funovics, MA; Rudas, M; Riedl, C; Pfarl, G Electrical impedance scanning in the differentiation of suspicious breast lesions: Comparison with mammography, ultrasound and histopathology
Rofo. 2002; 174(12):1522-1529 Doi: 10.1055/s-2002-35941
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kwasny, W; Tausch, C; Haid, A; Stierer, M; Konstantiniuk, P; Wayand, U; Sevelda, P Early experience with the advanced breast biopsy instrumentation system in a multicentre study
Gynakol Geburtshilfliche Rundsch. 2002; 42(4): 212-216. Doi: 10.1159/000065156
PubMed FullText FullText_MUG

 

Riedl, CC; Pfarl, G; Helbich, TH; Memarsadeghi, M; Wagner, T; Rudas, M; Fuchsjager, M Comparison of wire versus carbon localization of non-palpable breast lesions
Rofo. 2002; 174(9):1126-1131 Doi: 10.1055/s-2002-33933
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2000

Kronberger, L; Steinschifter, W; Weblacher, M; Estelberger, W; Liebmann, PM; Rabl, H; Smola, M; Lax, SF; Mischinger, HJ; Schauenstein, E; Schauenstein, K Selective decrease of serum immunoglobulin G1 as marker for early stages of invasive breast cancer.
Breast Cancer Res Treat. 2000; 64(2):193-199 Doi: 10.1023/A:1006450205698
Web of Science PubMed FullText FullText_MUG

 

Mirzaei, S; Zajicek, SM; Knoll, P; Lipp, C; Lipp, RW; Salzer, H; Umek, H; Kohn, H Scintimammography enhances negative predictive value of non-invasive pre-operative assessment of breast lesions.
Eur J Surg Oncol. 2000; 26(8):738-741 Doi: 10.1053/ejso.2000.0995
Web of Science PubMed FullText FullText_MUG

 

Moinfar, F; Man, YG; Bratthauer, GL; Ratschek, M; Tavassoli, FA Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type (clinging ductal carcinoma in situ): a simulator of normal mammary epithelium.
Cancer. 2000; 88(9):2072-2081 Doi: 10.1002%2F%28SICI%291097-0142%2820000501%2988%3A9%3C2072%3A%3AAID-CNCR13%3E3.0.CO%3B2-H [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1999

Knez, I; Cerwenka, H; Moinfar, F; Hoff, M; Mächler, H; Anelli-Monti, M; Radner, H; Rigler, B Invasive ductal carcinoma of the male breast expanding from pacemaker pocket decubitus.
Pacing Clin Electrophysiol. 1999; 22(3):531-533 Doi: 10.1111/j.1540-8159.1999.tb00484.x (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

1997

Cerwenka, H; Hoff, M; Rosanelli, G; Hauser, H; Thalhammer, M; Smola, MG; Klimpfinger, M Experience with a high speed biopsy gun in breast cancer diagnosis.
Eur J Surg Oncol. 1997; 23(3):206-207 Doi: 10.1016/S0748-7983(97)92268-X
Web of Science PubMed FullText FullText_MUG

 

Pedevilla, M Enhancement velocity not necessarily reflective of contrast material uptake in breast MR imaging.
Radiology. 1997; 205(2):580-581 Doi: 10.1148/radiology.205.2.580-a [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

1995

Deutinger, M; Koller, R; Hoflehner, H; Pierer, G; Rehak, PH; Freilinger, G Results of various reconstructive methods after subcutaneous mastectomy and objective evaluation of tissue fibrosis with a new measurement procedure
Handchir Mikrochir Plast Chir. 1995; 27(3): 115-118.
PubMed Google Scholar

 

Hauser, H; Beham, A; Steindorfer, P; Schmidt, F; Smola, MG Malignant schwannoma of the breast.
Langenbecks Arch Chir. 1995; 380(6):350-353 Doi: 10.1007/BF00207224 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

1994

Bier, B; Douglas-Jones, A; Tötsch, M; Dockhorn-Dworniczak, B; Böcker, W; Jasani, B; Schmid, KW Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions.
Breast Cancer Res Treat. 1994; 30(3): 213-221. Doi: 10.1007/BF00665963
Web of Science PubMed FullText FullText_MUG

 

1993

Hoflehner, H; Pierer, G; Rehak, P Mammacompliance: an objective technique for measuring capsular fibrosis.
PLAST RECONSTR SURG. 1993; 92(6): 1078-1084. Doi: 10.1097/00006534-199311000-00013
Web of Science PubMed FullText FullText_MUG

 

1992

Hauser, H; Beham, A; Steindorfer, P; Smola, MG; Fruhwirth, H; Klimpfinger, M Breast cancer in the catchment area of the Graz Institute of Pathology. Evaluation of morphologic parameters based on 1,510 cases.
Wien Klin Wochenschr. 1992; 104(23):717-720
Web of Science PubMed

 

1991

Buchberger, W; Penz, T; Strasser, K; Tötsch, M The radiological diagnosis of the male breast. Mammography, sonography and pathohistological correlation.
Rofo. 1991; 155(3): 260-266. Doi: 10.1055/s-2008-1033258
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1990

Schmid, KW; Hittmair, A; Tötsch, M; Müller, E; Zaimet, A; Tauscher, T; Dünser, M; Ofner, D Metallothionein expression in normal endometrium and cancers of the uterus, ovary and breast.
Gynakol Rundsch. 1990; 30 Suppl 1(5): 150-151. Doi: 10.1159/000271421
PubMed FullText FullText_MUG Google Scholar

 

1989

Luschin-Ebengreuth, G; Scharnagl, E A case of macromastia in pregnancy
Gynakol Rundsch. 1989; 29 Suppl 2(6): 335-337. Doi: 10.1159/000271103 (- Case Report)
PubMed FullText FullText_MUG

 

1985

Beham, A; Wirnsberger, G; Höfler, H; Helleis, G; Denk, H Lectin binding of breast cancers
Verh Dtsch Ges Pathol. 1985; 69(18): 207-211.
PubMed

 

Hackl, A Radiotherapy aspects in the treatment of breast cancer
Wien Med Wochenschr. 1985; 135(23-24):587-590
Web of Science PubMed

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum